EN DE
Watch Skylight Health Group Inc. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Skylight Health Group Inc. (SLHGF) fair value: what the stock is really worth

As of Sep 25, 2026: fair value (intrinsic value) of Skylight Health Group Inc. stock $0.00, price $0.00, upside +170.0%, quality 43 out of 100. Rating: strongly undervalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US · Home Canada · ISIN CA83086L2057

SH Skylight Health Group Inc. logo Thin data Nov 12, 2026

Skylight Health Group Inc.

SLHGF · US
Cheap, value-trap risk

The stock costs 63% less than our calculation considers fair.

Fair value $0.0003 · Strongly undervalued
Revenue last quarter +140% vs. a year ago.
Quality 43/100
Mixed Growth (revenue 5y +610.5 %/yr in USD)
Loss-making · -37.8% net margin (TTM)
Negative free cash flow
Trails peers (2/7)
Narrow moat 6/100 · thin data
Thin data
⚠ Thinly traded
Watch Skylight Health Group Inc. for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$7.25 $0.0001 Fair Value $0.0003 Oct 2019 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.

How to read this chart

60‑month range $0.0001 – $7.25 · fair‑value band $0.0002 – $0.0004 · the $0.0001 price screens below the $0.0003 fair value. As of Nov 12, 2026.

Follow Skylight Health Group in your weekly email

Every Wednesday you see whether Skylight Health Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Skylight Health Group Inc. operates as a healthcare services and technology company in the United States.

Show moreShow less

The company operates the US multi-state primary care health network, which provides a range of services from primary and urgent care, sub-specialty, allied health and wellness, and laboratory/diagnostic testing. It also provides healthcare services for older and disabled patients.

The company was formerly known as CB2 Insights Inc. and changed its name to Skylight Health Group Inc. in November 2020. Skylight Health Group Inc. was founded in 2014 and is headquartered in Mississauga, Canada.

Stock analysis

Skylight Health Group Inc. (SLHGF) currently trades at $0.0001, while our model-based Fair Value estimate is $0.0003, implying the stock looks roughly 63% undervalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 86/100, which puts the data coverage at low.

Scenario range: $0.0002 (bear) to $0.0004 (bull), the price of $0.0001 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 43/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Skylight Health Group Inc. reported revenue of C$27.2M in FY2021 versus C$280K in FY2017, a compound +213.8%/yr. Reported net income was −C$13.7M in FY2021.

Key figures

Market cap $3.9K Micro · EPS (TTM) $−0.1200 · Net margin −50.6% · Return on equity −96.9% · Return on assets (EBIT) −87.4% (5-year average) · Operating margin −26.9% · Revenue (TTM) C$54.0M · Revenue growth (YoY) +140%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 6 out of 100 (low confidence).

What moves the price

For context, the median of 10 Healthcare peers we cover trades at −5% fair-value upside, at 170%, SLHGF screens cheaper than that median.

Fair Value models

Bear $0.0002 Fair Value $0.0003 Bull $0.0004
Price $0.0001 · Upside +170.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
NCAV (Graham) $0.0002 $0.0003 $0.0004 51
All 1 models by family
Asset-Based
NCAV (Graham) $0.0002 $0.0003 $0.0004 51

Open the full fair value analysis →

Quality Score breakdown

Overall quality 43/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 13
How much profit the company makes from its sales and capital
Quality Growth 100
Are margins and returns getting better?
Cashflow 30
Do the profits arrive as real cash?
Financial strength 62
Debt, balance sheet and risk of trouble
Investment 50
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 29
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 13
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 34/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−10,229.7% (2016) → −80.5% (2021)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2021 is a loss year, no rate is defined from a loss
not computed

Watch SLHGF, get fair value alerts →

Compare Skylight Health Group Inc. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 249 stocks

Beats the industry median on 2/6 measures
Overall it trails its industry peers.
Valuation
Quality Score 43 · Bottom 25%
Fair Value upside +170.0% · Top 25%
Profitability
Return on assets −21.0% · Bottom 25%
Net margin (12 months) −37.8% · Bottom 25%
Operating margin (12 months) −26.9% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 139.7% · Top 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 33
FUTURE (revenue growth)100 · sector 32
PAST (return on equity)0 · sector 31
HEALTH (low debt)0 · sector 90
DIVIDEND (yield)0 · sector 39

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Fresenius Medical Care AG FMS $22.22 $46.55 +110% vs SLHGF
Aier Eye Hospital Group 300015 ¥8.68 ¥10.88 +25% vs SLHGF
DaVita Inc DVA $183.50 $218.90 +19% vs SLHGF
HCA Healthcare, Inc HCA $506.04 $547.34 +8% vs SLHGF
Tenet Healthcare Corporation THC $292.97 $279.20 −5% vs SLHGF
The Ensign Group ENSG $186.19 $140.09 −25% vs SLHGF
Encompass Health Corporation EHC $142.24 $94.81 −33% vs SLHGF
Fresenius SE FRE €52.82 €34.77 −34% vs SLHGF
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,604 ₹5,234 −39% vs SLHGF
Dr. Sulaiman Al Habib Medical Services Group 4013 212.90 SAR 109.45 SAR −49% vs SLHGF

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Average Down CalculatorFree calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Skylight Health Group Inc.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Skylight Health Group Inc. Fair Value". https://www.fairvalue-calculator.com/stock/SLHGF

Frequently asked questions

Is Skylight Health Group Inc. (SLHGF) overvalued or undervalued?
As of Nov 12, 2026, our model estimates a fair value of $0.0003 versus the last price from Sep 25, 2026 of $0.0001, about +170% upside (undervalued).
What is the fair value of SLHGF?
Our model-based fair value for Skylight Health Group Inc. is $0.0003 (as of Nov 12, 2026), built from audited fundamentals. Last price (from Sep 25, 2026): $0.0001.
What is the quality score of SLHGF?
Skylight Health Group Inc. has a Quality Score of 43/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Skylight Health Group Inc. (SLHGF)?
Our model-based price target is the fair value of $0.0003 (as of Nov 12, 2026) from 1 valuation models. Cautious scenario $0.0002, optimistic scenario $0.0004. It is a calculation from audited fundamentals, not an analyst target.
What is the Skylight Health Group Inc. stock forecast for 2026?
Our models put fair value at $0.0003, about +170% upside versus the last price from Sep 25, 2026 of $0.0001 (undervalued). Cautious scenario $0.0002, optimistic scenario $0.0004. The calculation is refreshed regularly with new filings.
What is the revenue of Skylight Health Group Inc. (SLHGF)?
Skylight Health Group Inc. reported trailing-twelve-month revenue of about C$54.0M (latest available figure, as of Nov 12, 2026).
What is the intrinsic value of Skylight Health Group Inc. (SLHGF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Skylight Health Group Inc. it is $0.0003 per share (as of Nov 12, 2026), against a price of $0.0001. It is the blended result of 1 valuation models in 1 family (Asset-Based).
Is Skylight Health Group Inc. stock overvalued or undervalued in 2026?
As of Nov 12, 2026, SLHGF trades below its calculated fair value: price $0.0001, fair value $0.0003, a gap of about +170% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SLHGF?
No. The price is what the market pays today ($0.0001); the fair value is what the company's own numbers justify ($0.0003). For Skylight Health Group Inc. the two are $0.0002 per share apart. That gap is exactly why we show both numbers side by side.
How much is Skylight Health Group Inc. worth?
The market values Skylight Health Group Inc. at about $3.9K (market capitalisation, as of Nov 12, 2026). Per share that is $0.0001; our models calculate a fair value of $0.0003 per share.
What do the bullish and bearish scenarios say about SLHGF?
Our models span a range for Skylight Health Group Inc.: cautious scenario $0.0002, base $0.0003, optimistic $0.0004 per share (as of Nov 12, 2026, price $0.0001). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Skylight Health Group Inc. (SLHGF)?
Balance-sheet figures for Skylight Health Group Inc. (as of Nov 12, 2026): return on equity −96.9%. They feed the Quality Score of 43/100, which measures business quality independently of the share price.
Which stocks are comparable to Skylight Health Group Inc.?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Skylight Health Group Inc. stock attractive at the current price?
The data as of Nov 12, 2026: price $0.0001, calculated fair value $0.0003 (+170%), Quality Score 43/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SLHGF calculated?
We run Skylight Health Group Inc. through 1 models from 1 family: Asset-Based. Every model gets the same audited fundamentals; the fair value of $0.0003 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0% above its aggregate fair value. Skylight Health Group Inc. currently trades 63% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Skylight Health Group Inc. (SLHGF)?
The latest price we hold is from Sep 25, 2026 and stands at $0.0001. Our model-based fair value is $0.0003, about +170% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Skylight Health Group Inc. right now?
The large discount to fair value meets weak quality (43/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($0.0002). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Skylight Health Group Inc.

How large is the market capitalisation of Skylight Health Group Inc. (SLHGF)?
The market capitalisation of Skylight Health Group Inc. is $3.9K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Skylight Health Group Inc. (SLHGF)?
Earnings per share at Skylight Health Group Inc. are $−0.1200. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Skylight Health Group Inc. (SLHGF)?
The net margin of Skylight Health Group Inc. is −50.6% (fiscal year 2021). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Skylight Health Group Inc. (SLHGF)?
The return on equity (ROE) of Skylight Health Group Inc. is −96.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Skylight Health Group Inc. (SLHGF)?
On an EBIT basis the return on assets of Skylight Health Group Inc. is −87.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Skylight Health Group Inc. (SLHGF)?
The operating margin of Skylight Health Group Inc. is −26.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Skylight Health Group Inc. (SLHGF)?
Revenue at Skylight Health Group Inc. is growing +140% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Skylight Health Group Inc. (SLHGF) generate?
The free cash flow of Skylight Health Group Inc. is −C$11.7M (fiscal year 2021). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Skylight Health Group Inc. (SLHGF) carry?
The net debt of Skylight Health Group Inc. is C$4.5M (fiscal year 2021). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Skylight Health Group Inc. in the live analysis

One click puts Skylight Health Group Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.